{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:29:06Z","timestamp":1791664146684,"version":"4.3.4"},"reference-count":31,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"unspecified","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["CH\/16\/2\/32089 and FS\/CRA\/22\/23034"],"award-info":[{"award-number":["CH\/16\/2\/32089 and FS\/CRA\/22\/23034"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,8,11]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The neutrophil-to-lymphocyte ratio (NLR) is defined as the ratio of neutrophils to lymphocytes measured in the full blood count. It has been studied across a range of conditions including cancer, sepsis and stroke. It has been proven that in patients with heart failure (HF) with reduced ejection fraction (HF-rEF), an elevated NLR reflects a higher risk of adverse outcomes. The aim of this study is to identify which clinical or cardiovascular magnetic resonance (CMR) factors are associated with an elevated NLR in patients with HF-rEF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>This study was an analysis of the MATCH registry (MyocArdial Tissue Characteristics in patients with heart failure according to glycaemic status), a prospectively recruited registry of patients presenting with a new diagnosis of HF and referred to our centre for a CMR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Single-centre study performed in the Advanced Imaging Centre, Leeds General Infirmary, UK. Data collection took place between February 2018 and March 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Patients (N=605) with newly diagnosed HF-rEF referred for CMR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Participants underwent clinical assessment, medication review, full blood count and CMR on the same day. The CMR protocol included quantitative assessment of myocardial blood flow at stress and rest, late gadolinium enhancement imaging and parametric mapping. Association between NLR, clinical and CMR parameters was examined by linear regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The factors which were found to be significantly associated with an elevated NLR were age, atrial fibrillation, N-terminal pro-B-type natriuretic peptide (NT-proBNP), presence of ischaemic fibrosis and myocardial perfusion reserve (MPR). There was no association between NLR and CMR markers of inflammation (native T1 and T2). On multiple regression after correction for age, atrial fibrillation, New York Heart Association classification and left ventricular ejection fraction, the association between NLR and presence of ischaemic fibrosis (coefficient 0.68, 95%\u2009CI 0.23 to 1.12, p=0.003) and NT-proBNP (coefficient 0.0002, 95%\u2009CI 0.00006 to 0.0003, p=0.002) remained significant. However, the association between MPR was no longer significant (coefficient \u22120.09, 95%\u2009CI \u22120.28 to 0.09, p=0.330).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients with HF with elevated NLR, these findings show an association with worsening congestion (NT-proBNP) and occult coronary artery disease (ischaemic fibrosis). Further studies are required to demonstrate if this accounts for the adverse prognosis. Importantly, there was no association between myocardial inflammation or oedema and NLR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-101707","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:25:32Z","timestamp":1756315532000},"page":"e101707","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and cardiovascular magnetic resonance factors associated with elevated neutrophil-to-lymphocyte ratio in patients with heart failure: an analysis of a single-centre, prospective registry"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2666-8359","authenticated-orcid":false,"given":"Patrick","family":"Thompson","sequence":"first","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie","family":"Duckett","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca","family":"Tomoaia","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasim","family":"Javed","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Anderton","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Dall\u2019Armellina","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eylem","family":"Levelt","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E D","family":"Saunderson","sequence":"additional","affiliation":[{"name":"Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kellman","sequence":"additional","affiliation":[{"name":"Laboratory of Cardiac Energetics, National Heart, Lung, Blood Institute, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Pierre","family":"Greenwood","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK"},{"name":"Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia"},{"name":"University of Melbourne and Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0997-4384","authenticated-orcid":false,"given":"Sven","family":"Plein","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cubbon","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P","family":"Swoboda","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"2025123106482135000_15.8.e101707.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht278"},{"key":"2025123106482135000_15.8.e101707.2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac013"},{"key":"2025123106482135000_15.8.e101707.3","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ejhf.1768","article-title":"The Heart Failure Association Atlas: rationale, objectives, and methods","volume":"22","author":"Seferovi\u0107","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2025123106482135000_15.8.e101707.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2019.10.023"},{"key":"2025123106482135000_15.8.e101707.5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/TA.0000000000001266","article-title":"Neutrophil-to-lymphocyte ratio in trauma patients","volume":"82","author":"Park","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"key":"2025123106482135000_15.8.e101707.6","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.686983","article-title":"Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Stroke: A Systematic Review and Meta-Analysis","volume":"12","author":"Li","year":"2021","journal-title":"Front Neurol"},{"key":"2025123106482135000_15.8.e101707.7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061308","article-title":"Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study","volume":"13","author":"Lee","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025123106482135000_15.8.e101707.8","doi-asserted-by":"publisher","DOI":"10.4149\/BLL_2021_078"},{"key":"2025123106482135000_15.8.e101707.9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79431-7","article-title":"Neutrophil-to-lymphocyte ratio and mortality in the United States general population","volume":"11","author":"Song","year":"2021","journal-title":"Sci Rep"},{"key":"2025123106482135000_15.8.e101707.10","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-018-0472-y"},{"key":"2025123106482135000_15.8.e101707.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-023-03572-6","article-title":"Neutrophil to lymphocyte ratio (NLR) prognostic effects on heart failure; a systematic review and meta-analysis","volume":"23","author":"Vakhshoori","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"2025123106482135000_15.8.e101707.12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20163879","article-title":"Inflammation and Cardiovascular Diseases: The Most Recent Findings","volume":"20","author":"Sorriento","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025123106482135000_15.8.e101707.13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020557","article-title":"Neutrophil-Lymphocyte Ratio in Patients with Acute Heart Failure Predicts In-Hospital and Long-Term Mortality","volume":"9","author":"Cho","year":"2020","journal-title":"J Clin Med"},{"key":"2025123106482135000_15.8.e101707.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.12.019"},{"key":"2025123106482135000_15.8.e101707.15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MCA.0000000000001040","article-title":"The prognostic value of neutrophil-to-lymphocyte ratio across all stages of coronary artery disease","volume":"33","author":"Agarwal","year":"2022","journal-title":"Coron Artery Dis"},{"key":"2025123106482135000_15.8.e101707.16","doi-asserted-by":"crossref","DOI":"10.1186\/1532-429X-18-S1-T10","article-title":"Essentials of cardiac MRI in clinical practice","volume":"18","author":"Piersson","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"2025123106482135000_15.8.e101707.17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2025123106482135000_15.8.e101707.18","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001063"},{"key":"2025123106482135000_15.8.e101707.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.09.072"},{"key":"2025123106482135000_15.8.e101707.20","doi-asserted-by":"crossref","DOI":"10.1093\/ehjimp\/qyae047","article-title":"CMR characterization of patients with heart failure and left bundle branch block","volume":"2","author":"Tomoaia","year":"2024","journal-title":"Eur Heart J Imaging Methods Pract"},{"key":"2025123106482135000_15.8.e101707.21","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002429","article-title":"Early prediction of left ventricular function improvement in patients with new-onset heart failure and presumed non-ischaemic aetiology","volume":"10","author":"Goh","year":"2023","journal-title":"Open Heart"},{"key":"2025123106482135000_15.8.e101707.22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1116110108"},{"key":"2025123106482135000_15.8.e101707.23","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/ehf2.13424","article-title":"Neutrophil-to-lymphocyte ratio and outcomes in patients with new-onset or worsening heart failure with reduced and preserved ejection fraction","volume":"8","author":"Curran","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2025123106482135000_15.8.e101707.24","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-017-0337-9"},{"key":"2025123106482135000_15.8.e101707.25","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000143059.68996.A7"},{"key":"2025123106482135000_15.8.e101707.26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10238-024-01340-0","article-title":"Clinical impact of transient lymphopenia","volume":"24","author":"Petramala","year":"2024","journal-title":"Clin Exp Med"},{"key":"2025123106482135000_15.8.e101707.27","doi-asserted-by":"crossref","unstructured":"Guo X , Ma L . Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol-related inflammatory parameters as predictors. In: Coronary artery disease, Vol 34. Lippincott Williams and Wilkins, 2023: 66\u201377. Available: https:\/\/doi.org\/10.1097\/MCA.0000000000001198","DOI":"10.1097\/MCA.0000000000001198"},{"key":"2025123106482135000_15.8.e101707.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914"},{"key":"2025123106482135000_15.8.e101707.29","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.0386"},{"key":"2025123106482135000_15.8.e101707.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1701719"},{"key":"2025123106482135000_15.8.e101707.31","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/ejh.13845","article-title":"Clonal haematopoiesis of indeterminate potential and impaired kidney function-A Danish general population study with 11\u2009years follow-up","volume":"109","author":"Larsen","year":"2022","journal-title":"Eur J Haematol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-101707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:51:06Z","timestamp":1767192666000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-101707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,27]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/bmjopen-2025-101707"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-101707","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}